Search - tctmd.com

Displaying 421 - 440 of 965

Sort: Relevancy | Date

News Daily News

Burst Balloons With Sapien 3 Ultra Prompt ‘Urgent Field Safety Notice’ and Canadian Recall

Shelley Wood

July 22, 2019

News Industry News

SENSE Data Shows DX System is Equivalent to Dual-Chamber ICDs and Superior to Single-Chamber in AHRE Detection

July 22, 2019

News Industry News

Nanowear Announces Clinical Launch of NanoSENSE, a Heart Failure Management and Alert Diagnostic Validation Study

July 22, 2019

News Conference News SCCT 2019

Chest Pain Rule-Out? For Two ED Scores, It’s a Draw

Yael L. Maxwell

July 19, 2019

News Daily News

Machine Learning Helps Predict In-Hospital Mortality Post-TAVR, but Skepticism Abounds

Todd Neale

July 19, 2019

News Daily News

Intensive Lipid-Lowering Slashes CVD in Elderly ACS Patients

Michael O'Riordan

July 19, 2019

News Conference News SCCT 2019

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

Yael L. Maxwell

July 18, 2019

News Daily News

Hypertension From Top to Bottom: Don’t Ignore Diastolic BP

Todd Neale

July 17, 2019

News Daily News

CV Risk Factors in Youth May Prove Indelible for Later CAD

Marcus A. Banks

July 17, 2019

News Daily News

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Michael O'Riordan

July 17, 2019

News Industry News

New study finds both components of blood pressure predict heart attack, stroke risk

July 17, 2019

News Conference News SCCT 2019

CTA or Function Tests in High-risk Chest Pain and No Known CAD: Debate Goes On

Yael L. Maxwell

July 16, 2019

News Daily News

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

Shelley Wood

July 16, 2019

News Daily News

Large, US Study Supports Single High-Sensitivity Troponin I Test for Suspected Acute MI

Todd Neale

July 16, 2019

News Industry News

Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina

July 16, 2019

News Daily News

Race, Wealth, and Neighborhood Predict Bystander CPR in Children

Marcus A. Banks

July 16, 2019

News Daily News

Silent MI Often Precedes Sudden Cardiac Death, Finnish Data Confirm

Caitlin E. Cox

July 15, 2019

News Conference News SCCT 2019

Time to Ease Up on Prior Authorization for PCSK9 Inhibitors?

Yael L. Maxwell

July 15, 2019

News Industry News

Endotronix Enrolls First Patient in SIRONA II CE Mark Trial

July 15, 2019

News Industry News

FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease

July 15, 2019

Advertisement

Burst Balloons With Sapien 3 Ultra Prompt ‘Urgent Field Safety Notice’ and Canadian Recall

SENSE Data Shows DX System is Equivalent to Dual-Chamber ICDs and Superior to Single-Chamber in AHRE Detection

Nanowear Announces Clinical Launch of NanoSENSE, a Heart Failure Management and Alert Diagnostic Validation Study

Chest Pain Rule-Out? For Two ED Scores, It’s a Draw

Machine Learning Helps Predict In-Hospital Mortality Post-TAVR, but Skepticism Abounds

Intensive Lipid-Lowering Slashes CVD in Elderly ACS Patients

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

Hypertension From Top to Bottom: Don’t Ignore Diastolic BP

CV Risk Factors in Youth May Prove Indelible for Later CAD

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

New study finds both components of blood pressure predict heart attack, stroke risk

CTA or Function Tests in High-risk Chest Pain and No Known CAD: Debate Goes On

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

Large, US Study Supports Single High-Sensitivity Troponin I Test for Suspected Acute MI

Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina

Race, Wealth, and Neighborhood Predict Bystander CPR in Children

Silent MI Often Precedes Sudden Cardiac Death, Finnish Data Confirm

Time to Ease Up on Prior Authorization for PCSK9 Inhibitors?

Endotronix Enrolls First Patient in SIRONA II CE Mark Trial

FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content